CORA TERMS OF SERVICE
Last Updated: February 24, 2026
IMPORTANT: PLEASE READ THESE TERMS CAREFULLY BEFORE USING CORA. BY CHECKING THE ACCEPTANCE BOX AND CLICKING "ACCEPT," YOU AGREE TO BE BOUND BY THESE TERMS. IF YOU DO NOT AGREE, DO NOT USE THE SERVICE.
This Terms of Service agreement ("Agreement") is entered into between Max Output LLC, a North Carolina limited liability company ("Provider," "we," "us," or "our"), and the entity or individual accessing or using the Cora platform ("Customer," "you," or "your"). This Agreement is informed by industry-standard cloud service agreement frameworks with additional terms specific to AI-powered services and clinical research workflows.
1. DEFINITIONS
"Acceptable Use Policy" or "AUP" means Section 5 of this Agreement, which governs permitted and prohibited uses of the Service.
"AI Output" means any text, data, analysis, citation, or other content generated by the Service in response to a User's query or interaction.
"Authorized Users" means individuals who are employees, contractors, or agents of Customer who have been authorized by Customer to access and use the Service under this Agreement.
"Confidential Information" means any non-public information disclosed by either party to the other in connection with this Agreement that is designated as confidential or that a reasonable person would understand to be confidential given the nature of the information and circumstances of disclosure. For clarity, Confidential Information includes, but is not limited to, uploaded Protocol Documents, AI Outputs, system prompts, RAG architecture, and business terms.
"Customer Data" means all data, content, and information submitted to the Service by or on behalf of Customer, including Protocol Documents, User queries, and account information.
"Effective Date" means the date on which Customer first accepts this Agreement by clicking the acceptance mechanism in the Service.
"Pilot Period" means the initial sixty (60) day evaluation period commencing on the Effective Date.
"Protocol Documents" means clinical trial protocols, study documents, and related materials uploaded to the Service by Customer. Protocol Documents may include confidential and proprietary information owned by third parties, including pharmaceutical sponsors.
"Service" means the Cora platform, accessible at https://cora.getmaxoutput.com, including all features, functionality, and AI-powered capabilities provided thereunder.
"Third-Party Confidential Information" means Confidential Information owned by a third party (including pharmaceutical sponsors) that is disclosed to Provider through Customer's use of the Service, including but not limited to Protocol Documents subject to Confidential Disclosure Agreements between Customer and third parties.
2. DESCRIPTION OF SERVICE
2.1 What Cora Is
Cora is an AI-powered protocol reference tool. It is a web-based application that allows clinical research site staff to upload clinical trial protocol documents in PDF format and ask natural-language questions about those protocols, receiving citation-backed answers generated through Retrieval-Augmented Generation (RAG) technology.
2.2 What Cora Is NOT
THE SERVICE IS NOT A MEDICAL DEVICE. It does not diagnose, treat, cure, prevent, or mitigate any disease or condition. It does not acquire, process, or analyze signals from the human body.
THE SERVICE IS NOT A CLINICAL DECISION SUPPORT (CDS) SYSTEM. It does not recommend treatments, predict patient outcomes, or provide clinical guidance. It is an administrative reference tool that retrieves and presents information already contained in documents uploaded by the Customer.
THE SERVICE IS NOT A SOURCE OF MEDICAL ADVICE. Every response generated by the Service includes a disclaimer stating this explicitly.
THE SERVICE IS NOT DESIGNED TO PROCESS PROTECTED HEALTH INFORMATION (PHI). The Service processes study design documents (procedures, eligibility criteria, dosing schedules), not patient data. See Section 5.3 for PHI restrictions.
THE SERVICE IS NOT GUARANTEED TO BE 100% ACCURATE. AI-generated outputs may contain errors. See Section 4 for complete AI disclaimers.
3. ACCOUNT REGISTRATION AND ACCESS
3.1 Account Creation
To access the Service, Customer must create an account by providing a valid email address and completing email verification via one-time password (OTP). Customer is responsible for maintaining the accuracy of account information.
3.2 Account Security
Customer is responsible for all activity that occurs under its account. Customer must immediately notify Provider at founders@maxoutput.ai if Customer becomes aware of any unauthorized access to or use of the Service.
3.3 Authorized Users
Customer may permit Authorized Users to access the Service under Customer's account. Customer is responsible for the acts and omissions of all Authorized Users and must ensure that all Authorized Users comply with this Agreement, including the Acceptable Use Policy.
3.4 Access Suspension
Provider may immediately suspend Customer's access to the Service if Provider reasonably determines that Customer or any Authorized User has violated the Acceptable Use Policy (Section 5), particularly regarding the upload of Protected Health Information or unauthorized third-party documents. Provider will use commercially reasonable efforts to provide notice before or promptly after any suspension.
4. AI-SPECIFIC TERMS
4.1 Nature of AI Outputs
The Service utilizes artificial intelligence and machine learning technologies, including Large Language Models (LLMs) and Retrieval-Augmented Generation (RAG), to generate responses to Customer queries. Due to the inherent probabilistic nature of these technologies, AI Outputs may be inaccurate, incomplete, misleading, or contain errors (commonly referred to as "hallucinations"). Provider makes no representations or warranties, express or implied, regarding the accuracy, reliability, completeness, or factual correctness of AI Outputs.
AI OUTPUTS ARE PROVIDED "AS IS" AND MUST NOT BE RELIED UPON AS ABSOLUTE STATEMENTS OF FACT.
4.2 Output Verification Responsibility (Human-in-the-Loop)
THE SERVICE IS AN ADMINISTRATIVE REFERENCE TOOL AND IS NOT A SUBSTITUTE FOR PROFESSIONAL HUMAN OVERSIGHT, CLINICAL JUDGMENT, OR ADHERENCE TO REGULATORY COMPLIANCE PROTOCOLS.
Customer and its Authorized Users maintain absolute responsibility for independently reviewing, verifying, and validating all AI Outputs against the original, approved source documents (including sponsor-provided clinical trial protocols) before utilizing or relying upon such AI Outputs for any operational, administrative, or clinical purpose.
Any reliance on unverified AI Outputs for clinical trial operations constitutes a material breach of this Agreement. Customer acknowledges that Provider bears no liability for outcomes resulting from reliance on unverified AI Outputs.
4.3 Confidence Scoring and Warnings
The Service assigns confidence levels (HIGH, MEDIUM, or LOW) to AI Outputs. When confidence is LOW, the Service displays a visible warning and recommends verification with the Principal Investigator. The presence of a HIGH or MEDIUM confidence score does not constitute a guarantee of accuracy. All AI Outputs, regardless of confidence level, must be verified against source documents.
4.4 No Model Training on Customer Data
Provider expressly agrees that it shall not use Customer Data — including uploaded Protocol Documents, User queries, chat histories, or AI Outputs — to train, fine-tune, or iteratively improve any foundational large language models, neural networks, or machine learning algorithms.
Customer Data processed through the Service's AI infrastructure (AWS Bedrock) is not used by the infrastructure provider (Amazon Web Services) to train or improve AI models. Protocol text transmitted for AI processing is not retained by the AI infrastructure provider after the response is generated.
4.5 Third-Party AI Infrastructure
The Service utilizes AWS Bedrock (provided by Amazon Web Services) as its AI infrastructure provider for language model inference and embedding generation. Customer acknowledges that Customer Data is transmitted to AWS Bedrock for processing and that such processing is subject to AWS's service terms. Customer's use of the Service must also comply with the acceptable use policies of underlying infrastructure providers; violations of such policies constitute a breach of this Agreement. Provider has selected AWS Bedrock specifically because it does not use customer content for model training under its standard terms of service.
4.6 Accuracy Disclaimer
An accuracy disclaimer is displayed in the Service at all times: "Cora is an AI assistant. All responses should be verified against source documents before making clinical decisions." This disclaimer is a material term of this Agreement and reflects the operational reality of AI-generated content.
5. ACCEPTABLE USE POLICY
5.1 Permitted Uses
Customer may use the Service solely for the following purposes:
- Uploading clinical trial protocol documents in PDF format
- Querying uploaded protocols using the Service's natural-language interface
- Reviewing, exporting, and sharing AI Outputs with Customer's site personnel and Principal Investigators
- Providing feedback on AI Output quality
- Other internal, administrative reference purposes related to clinical trial operations
5.2 Prohibited Uses
Customer and its Authorized Users shall NOT:
(a) Use the Service to make clinical decisions regarding patient care, treatment, diagnosis, or trial eligibility without independently verifying AI Outputs against source documents;
(b) Upload, transmit, or enter Protected Health Information (PHI) into the Service (see Section 5.3);
(c) Upload documents for which Customer does not possess the necessary rights, licenses, permissions, or authorizations, including documents that would violate any existing Confidential Disclosure Agreement, non-disclosure agreement, or sponsor mandate;
(d) Use the Service to build a competitive product, perform competitive benchmarking, or reverse-engineer, decompile, or disassemble any aspect of the Service, including its AI architecture, system prompts, or RAG pipeline;
(e) Attempt to extract, reconstruct, or reverse-engineer the Service's system prompts, proprietary algorithms, or prompt engineering techniques;
(f) Circumvent, disable, or interfere with the Service's security features, including PII/PHI detection filters;
(g) Use the Service in any manner that violates applicable federal, state, or local laws or regulations;
(h) Share login credentials or permit unauthorized individuals to access the Service;
(i) Use the Service to generate content that is defamatory, fraudulent, or in violation of third-party intellectual property rights;
(j) Misrepresent AI Outputs as having been independently verified when they have not been.
5.3 Absolute Prohibition on Protected Health Information
THE SERVICE IS NOT DESIGNED, INTENDED, OR AUTHORIZED FOR THE STORAGE, PROCESSING, OR TRANSMISSION OF PROTECTED HEALTH INFORMATION (PHI) AS DEFINED BY THE HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA). CUSTOMER AND ITS AUTHORIZED USERS ARE STRICTLY PROHIBITED FROM ENTERING, UPLOADING, OR TRANSMITTING ANY PHI, PERSONALLY IDENTIFIABLE PATIENT INFORMATION, OR PATIENT-SPECIFIC HEALTH DATA INTO THE SERVICE.
The Service implements automated detection filters designed to identify and block queries containing patient identifiers (including names, Social Security numbers, medical record numbers, dates of birth, addresses, phone numbers, and email addresses). These filters are provided on a "best-efforts" basis and are not guaranteed to be error-free, comprehensive, or infallible. The existence of these preventative measures does not relieve Customer of its absolute and primary obligation to refrain from inputting PHI into the Service.
5.4 User Warranty Regarding Upload Rights
By uploading any document to the Service, Customer represents and warrants that:
(a) Customer possesses all necessary licenses, permissions, and authorizations required to upload such document into the Service and to have it processed by the Service's AI infrastructure, including transmission to third-party sub-processors;
(b) Such upload does not violate any existing Confidential Disclosure Agreement (CDA), non-disclosure agreement, sponsor mandate, or other contractual obligation binding Customer;
(c) Customer has determined, in its sole judgment, that the use of the Service is consistent with Customer's obligations to the owners of the uploaded documents (including pharmaceutical sponsors);
(d) Customer acknowledges that it is solely responsible for ensuring that the use of the Service complies with all applicable institutional confidentiality policies and sponsor requirements.
5.5 Waiver of Privilege Warning
Customer acknowledges that uploading privileged or confidential information into any cloud-based AI service may, under certain circumstances, constitute a waiver of confidentiality privilege under applicable law. Customer is solely responsible for evaluating and accepting this risk with respect to any documents uploaded to the Service.
6. INTELLECTUAL PROPERTY
6.1 Customer Data
Customer retains all right, title, and interest in and to Customer Data, including uploaded Protocol Documents. Provider acquires no ownership rights in Customer Data by virtue of this Agreement.
6.2 AI Outputs
To the extent permitted by applicable law, Provider assigns to Customer all available right, title, and interest in AI Outputs generated specifically in response to Customer's queries. Customer acknowledges that: (a) AI Outputs are generated using third-party AI models and may not be eligible for copyright protection under current United States law; (b) AI Outputs may be similar or identical to outputs generated for other customers using different source documents; and (c) Provider makes no warranty against third-party infringement claims based on AI-generated text.
6.3 Provider Intellectual Property
Customer acknowledges that the Service, including its software, algorithms, RAG pipeline architecture, system prompts, user interface, and documentation, is the proprietary intellectual property of Provider. Nothing in this Agreement grants Customer any right, title, or interest in the Service beyond the limited access rights expressly set forth herein.
7. FEES AND PAYMENT
7.1 Pilot Fees
The fee for the Pilot Period is as set forth in the applicable order form, invoice, or pricing page at the time of purchase. Unless otherwise specified, fees are due in advance and are non-refundable except as expressly provided in this Agreement.
7.2 Post-Pilot Pricing
Following the Pilot Period, continued use of the Service is subject to the then-current pricing terms, which will be communicated to Customer prior to the conclusion of the Pilot Period. Customer is under no obligation to continue using the Service after the Pilot Period.
7.3 Protocol Definitions (for Billing Purposes)
For purposes of post-pilot billing:
(a) Protocol. A "Protocol" means one active clinical study. A single Protocol slot includes the original protocol document and up to five (5) amendments to that same study. Amendments to the same study do not constitute separate Protocols.
(b) Active Protocol. A Protocol is considered "active" for billing purposes if it has been uploaded to or queried within the current billing period.
(c) Fair Usage. The Service enforces included Protocol limits via soft notification, not hard lockout. If Customer exceeds the included number of Protocols in a billing period, Provider will notify Customer and apply per-Protocol overage fees as set forth in the applicable pricing terms. The Service will not restrict access to Protocols during active clinical operations.
7.4 Taxes
All fees are exclusive of applicable taxes. Customer is responsible for all taxes, duties, and governmental assessments arising from this Agreement, excluding taxes based on Provider's net income.
8. DATA HANDLING AND SECURITY
8.1 Data Security
Provider implements and maintains commercially reasonable administrative, technical, and physical safeguards to protect Customer Data, including:
(a) Encryption of data in transit using Transport Layer Security (TLS);
(b) Encryption of data at rest using AES-256 encryption;
(c) Multi-tenant data isolation using PostgreSQL row-level security (RLS) policies, ensuring that Customer's data is logically isolated from and inaccessible to other customers;
(d) Audit logging of all queries, responses, confidence scores, and response times;
(e) Rate limiting on API endpoints to prevent abuse;
(f) Security headers (X-Content-Type-Options, X-Frame-Options, Referrer-Policy, Cache-Control: no-store).
8.2 Data Location
All Customer Data is stored and processed on infrastructure located within the United States.
8.3 Privacy Policy
Provider's collection, use, and disclosure of personal information is governed by the Privacy Policy available at https://cora.getmaxoutput.com/privacy. The Privacy Policy is incorporated into this Agreement by reference.
8.4 Data Deletion
Upon termination of this Agreement or upon Customer's written request, Provider will permanently delete Customer's Protocol Documents, associated text chunks, vector embeddings, chat session history, and account information within thirty (30) days. Audit logs may be retained in anonymized form (with user identifiers removed) as described in the Privacy Policy. Upon Customer's request, Provider will issue a written Certificate of Destruction confirming that all primary records have been purged from production systems.
9. CONFIDENTIALITY
9.1 Mutual Obligations
Each party agrees to hold the other party's Confidential Information in strict confidence using no less than a reasonable degree of care, and in no event less than the degree of care used to protect its own confidential information of a similar nature. Neither party shall disclose the other party's Confidential Information to any third party except as expressly permitted by this Agreement.
9.2 Third-Party Confidential Information
Provider acknowledges that Protocol Documents may contain confidential and proprietary information owned by third parties, including pharmaceutical sponsors, and subject to Confidential Disclosure Agreements between Customer and such third parties ("Sponsor CDAs"). Provider agrees to protect such Third-Party Confidential Information with the same degree of care as Customer's own Confidential Information. Provider's sub-processors (as identified in the Privacy Policy) are bound by written agreements imposing equivalent confidentiality obligations.
9.3 Permitted Disclosures
A party may disclose the other party's Confidential Information: (a) to its employees, contractors, and agents who have a need to know and are bound by confidentiality obligations at least as restrictive as those in this Agreement; (b) as required by applicable law, regulation, or valid legal process, provided that the disclosing party gives reasonable prior notice to the other party (to the extent permitted by law).
9.4 Exclusions
Confidential Information does not include information that: (a) is or becomes publicly available through no fault of the receiving party; (b) was rightfully known by the receiving party prior to disclosure; (c) is independently developed by the receiving party without use of or reference to the disclosing party's Confidential Information; or (d) is rightfully received from a third party without restriction.
9.5 Survival of Confidentiality Obligations
Confidentiality obligations under this Section shall survive for a period of five (5) years from the date of disclosure of the applicable Confidential Information, except that obligations relating to trade secrets (including Protocol Documents designated as trade secrets by their owners) shall survive for as long as the information remains a trade secret under applicable law.
10. MEDICAL AND REGULATORY DISCLAIMER
10.1 Not a Medical Device
THE SERVICE IS NOT A MEDICAL DEVICE AS DEFINED UNDER THE FEDERAL FOOD, DRUG, AND COSMETIC ACT OR FDA REGULATIONS. THE SERVICE DOES NOT DIAGNOSE, TREAT, CURE, PREVENT, OR MITIGATE ANY DISEASE OR CONDITION. THE SERVICE DOES NOT ACQUIRE, PROCESS, OR ANALYZE SIGNALS FROM THE HUMAN BODY.
10.2 Not Clinical Decision Support
THE SERVICE IS NOT A CLINICAL DECISION SUPPORT (CDS) SYSTEM AS DEFINED UNDER SECTION 520(o)(1)(E) OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT (AS ADDED BY SECTION 3060(a) OF THE 21ST CENTURY CURES ACT). THE SERVICE IS AN ADMINISTRATIVE REFERENCE TOOL THAT RETRIEVES AND PRESENTS INFORMATION ALREADY CONTAINED IN DOCUMENTS UPLOADED BY THE CUSTOMER. THE SERVICE DOES NOT RECOMMEND TREATMENTS, PREDICT PATIENT OUTCOMES, ALTER CLINICAL WORKFLOWS, OR REPLACE THE INDEPENDENT PROFESSIONAL JUDGMENT OF HEALTHCARE PROVIDERS OR CLINICAL RESEARCH PROFESSIONALS.
10.3 Not a Substitute for Professional Judgment
THE SERVICE SUPPLEMENTS, BUT DOES NOT REPLACE, THE CUSTOMER'S OBLIGATION TO READ, UNDERSTAND, AND COMPLY WITH CLINICAL TRIAL PROTOCOLS, APPLICABLE REGULATIONS, AND INSTITUTIONAL POLICIES. ALL AI OUTPUTS MUST BE INDEPENDENTLY VERIFIED AGAINST ORIGINAL SOURCE DOCUMENTS BEFORE BEING USED IN ANY CLINICAL TRIAL CONTEXT.
10.4 Regulatory Compliance
Customer is solely responsible for ensuring that its use of the Service complies with all applicable laws, regulations, and institutional policies, including but not limited to FDA regulations, Good Clinical Practice (GCP) guidelines, and sponsor requirements.
11. LIMITATION OF LIABILITY
11.1 Cap on Liability
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, PROVIDER'S TOTAL AGGREGATE LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT SHALL NOT EXCEED THE TOTAL AMOUNT OF FEES ACTUALLY PAID BY CUSTOMER TO PROVIDER DURING THE TWELVE (12) MONTH PERIOD IMMEDIATELY PRECEDING THE CLAIM.
11.2 Exclusion of Damages
IN NO EVENT SHALL PROVIDER BE LIABLE FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, EXEMPLARY, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED TO: LOSS OF PROFITS OR REVENUE; BUSINESS INTERRUPTION; LOSS OF DATA OR CORRUPTION OF DATA; REGULATORY FINES OR PENALTIES; CLINICAL TRIAL DATA LOSS, CORRUPTION, OR INVALIDATION; PROTOCOL DEVIATIONS ARISING FROM RELIANCE ON AI OUTPUTS; OR COST OF PROCUREMENT OF SUBSTITUTE SERVICES, REGARDLESS OF THE THEORY OF LIABILITY (CONTRACT, TORT, STRICT LIABILITY, OR OTHERWISE) AND EVEN IF PROVIDER HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
11.3 Basis of the Bargain
Customer acknowledges that Provider has set its fees and entered into this Agreement in reliance upon the limitations of liability and disclaimers set forth herein, and that the same form an essential basis of the bargain between the parties.
12. INDEMNIFICATION
12.1 Customer Indemnification
Customer shall indemnify, defend, and hold harmless Provider and its officers, directors, employees, and agents from and against any and all claims, damages, losses, liabilities, costs, and expenses (including reasonable attorneys' fees) arising from or related to:
(a) Customer's or any Authorized User's violation of the Acceptable Use Policy, including but not limited to the entry of Protected Health Information into the Service;
(b) Customer's or any Authorized User's upload of documents in violation of any Confidential Disclosure Agreement, non-disclosure agreement, or other contractual obligation with third parties, including pharmaceutical sponsors;
(c) Customer's or any Authorized User's reliance on AI Outputs without independent verification against original source documents;
(d) Any claim by a third party (including pharmaceutical sponsors) arising from Customer's use of the Service in connection with such third party's confidential or proprietary information;
(e) Customer's violation of any applicable law or regulation in connection with its use of the Service.
12.2 Indemnification Obligations Are Uncapped
Customer's indemnification obligations under Section 12.1 are not subject to the limitation of liability set forth in Section 11. Customer's obligations to indemnify Provider for violations of the Acceptable Use Policy, unauthorized PHI entry, and third-party intellectual property or confidentiality breaches are unlimited.
13. TERM AND TERMINATION
13.1 Term
This Agreement commences on the Effective Date and continues for the Pilot Period (sixty (60) days), unless earlier terminated in accordance with this Section. Following the Pilot Period, the Agreement will continue on a month-to-month basis under the then-current pricing terms until terminated by either party.
13.2 Termination for Convenience
Either party may terminate this Agreement at the end of the Pilot Period or any subsequent monthly period by providing written notice at least fifteen (15) days prior to the end of the then-current period.
13.3 Termination for Breach
Either party may terminate this Agreement immediately upon written notice if the other party materially breaches this Agreement and fails to cure such breach within fifteen (15) days after receiving written notice of the breach. Notwithstanding the foregoing, Provider may terminate this Agreement immediately, without a cure period, upon any violation of the Acceptable Use Policy (Section 5).
13.4 Effect of Termination
Upon termination: (a) Customer's access to the Service will cease; (b) Provider will delete Customer Data in accordance with Section 8.4; (c) Sections 4 (AI-Specific Terms), 5.3 (PHI Prohibition), 6 (Intellectual Property), 9 (Confidentiality), 10 (Medical and Regulatory Disclaimer), 11 (Limitation of Liability), 12 (Indemnification), and 14 (Governing Law) shall survive termination.
14. GOVERNING LAW AND DISPUTE RESOLUTION
14.1 Governing Law
This Agreement is governed by and construed in accordance with the laws of the State of North Carolina, without regard to its conflict of laws principles.
14.2 Venue
Any legal action or proceeding arising under this Agreement shall be brought exclusively in the state or federal courts located in Mecklenburg County, North Carolina, and the parties consent to the personal jurisdiction and venue of such courts.
15. GENERAL PROVISIONS
15.1 Entire Agreement
This Agreement, together with the Privacy Policy and any order forms or invoices, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, proposals, and communications, whether oral or written.
15.2 Amendments
Provider may update these Terms by posting a revised version on the Service. Material changes will be communicated to Customer via the email address associated with Customer's account at least thirty (30) days prior to the effective date of the change. Customer's continued use of the Service after the effective date of any change constitutes acceptance of the updated Terms. If Customer does not agree to the updated Terms, Customer must stop using the Service and may terminate this Agreement.
15.3 Severability
If any provision of this Agreement is held to be invalid, illegal, or unenforceable, the remaining provisions shall continue in full force and effect.
15.4 Waiver
The failure of either party to enforce any right or provision of this Agreement shall not be deemed a waiver of such right or provision.
15.5 Assignment
Customer may not assign this Agreement without Provider's prior written consent. Provider may assign this Agreement in connection with a merger, acquisition, or sale of all or substantially all of its assets.
15.6 Notices
All notices under this Agreement shall be in writing and sent to the email addresses associated with each party's account. Notices to Provider shall be sent to: founders@maxoutput.ai. Notices are deemed received on the business day following transmission.
15.7 Force Majeure
Neither party shall be liable for any failure or delay in performing its obligations under this Agreement due to circumstances beyond its reasonable control, including but not limited to acts of God, natural disasters, pandemic, government actions, internet or telecommunications failures, or third-party service provider outages.
15.8 AI Disclosure
Customer acknowledges that the Service is powered by generative artificial intelligence technology. All responses generated by the Service are machine-generated and should be treated as AI-assisted outputs requiring human verification.